MPLTMapLight Therapeutics, Inc.同业对比
MapLight Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MPLT本股 | $513M#7 | 0.3x#1 | 1.5x#2 | — | — | -107.7%#12 | — | -46.3%#10 | — | — | — | — |
| STTK | $599M#1 | — | 2.8x#10 | 599.2x#11 | -82.5%#11 | 35.3%#3 | -5150.8%#11 | -23.1%#7 | — | — | — | — |
| CTMX | $588M#2 | — | 1.9x#5 | 7.7x#7 | -44.8%#9 | -154.5%#13 | -29.3%#4 | -5.7%#4 | -7.8%#2 | — | — | — |
| ANNX | — | — | — | — | — | -49.6%#10 | — | -111.1%#12 | — | — | — | — |
| ARVN | $541M#3 | 31.8x#4 | 1.0x#1 | 2.1x#2 | -0.3%#5 | 59.3%#2 | -45.1%#5 | -14.4%#6 | -25.3%#3 | — | — | — |
| ASMB | $531M#4 | 21.0x#3 | 1.7x#4 | 7.3x#6 | 153.5%#2 | 84.8%#1 | -16.8%#3 | -2.0%#3 | -4.4%#1 | — | 22.9%#6 | — |
| OVID | $529M#5 | — | 2.5x#8 | 73.0x#10 | 1181.3%#1 | 34.1%#4 | -585.2%#9 | -8.3%#5 | — | — | — | — |
| EOLS | $522M#6 | — | — | 1.8x#1 | 11.6%#4 | -2.4%#8 | -11.0%#2 | — | -40.5%#4 | 4#1 | 19.3%#7 | — |
| CAPR | $498M#8 | — | 2.0x#6 | — | -100.0%#13 | -159.6%#14 | — | -42.7%#9 | — | — | 41.9%#5 | — |
| IRD | $483M#9 | — | — | 34.0x#8 | 29.1%#3 | 13.8%#6 | -271.9%#8 | — | — | — | 326.8%#1 | — |
| INDP | $482M#10 | — | 42.4x#13 | — | — | -38.8%#9 | — | -183.3%#13 | — | — | 57.4%#4 | — |
| PBYI | $478M#11 | 18.2x#2 | 3.5x#11 | 2.1x#3 | -0.9%#6 | 2.8%#7 | 16.3%#1 | 22.5%#1 | — | — | 99.8%#3 | — |
| RLMD | $475M#12 | — | 2.3x#7 | 92548.4x#12 | -35.4%#8 | — | -1152275.3%#12 | 0.0%#2 | — | — | 164.9%#2 | — |
| ARCT | $450M#13 | — | 2.6x#9 | 5.5x#5 | -46.1%#10 | 18.7%#5 | -93.0%#6 | -38.3%#8 | -136.2%#5 | — | -12.7%#9 | — |
| PRTA | $429M#14 | — | 1.5x#3 | 44.3x#9 | -92.8%#12 | -99.6%#11 | -2216.4%#10 | -85.1%#11 | — | — | 2.2%#8 | — |
| SPRY | $421M#15 | — | 33.7x#12 | 5.0x#4 | -5.5%#7 | -2241.8%#15 | -212.9%#7 | -1369.1%#14 | -177.6%#6 | — | -57.5%#10 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议